unknown
Stage
1
Investors
About
AMADIX develops blood-based diagnostic tests for early cancer detection. Its PreveCol test is aimed at detecting colorectal cancer and advanced adenomas.
Explore AMADIX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.